Reaction #956699

ord-c2075802c5634941aff09722a869a1cf

Conditions

Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    Otherobtained in Reference Example 1

Procedure

Using commercially available 2-(pyridin-2-yl)-1H-benzo[d]imidazole (50 mg, 0.34 mmol) and (E)-2-[8-(bromomethyl)-3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene]propanenitrile (120 mg, 0.335 mmol) obtained in Reference Example 1, and in the same manner as in Reference Example 1A, the title compound (123 mg, 86%) was obtained.

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08969345B2uspto-grants-2015_03